Paper40959486
Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models.
Stelse-Masson S and 15 others. Nanotheranostics, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models. Papers, record 40959486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40959486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pancreatic Neoplasms | Major topic |
| Lutetium | Major topic |
| Nanoparticles | Major topic |
| Radiation-Sensitizing Agents | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Silicon Dioxide | |
| Monte Carlo Method |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8956786 | Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8956786 | PubMed |
| 2 | 35097226 | NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. | Clin Transl Radiat Oncol | 2022 | https://conductscience.org/library/papers/35097226 | PubMed |
| 3 | 29192263 | Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids. | Sci Rep | 2017 | https://conductscience.org/library/papers/29192263 | PubMed |
| 4 | 30589178 | CT/MRI-Guided Synergistic Radiotherapy and X-ray Inducible Photodynamic Therapy Using Tb-Doped Gd-W-Nanoscintillators. | Angew Chem Int Ed Engl | 2019 | https://conductscience.org/library/papers/30589178 | PubMed |
| 5 | 3562895 | Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors. | Radiother Oncol | 1987 | https://conductscience.org/library/papers/3562895 | PubMed |
| 6 | 27939934 | Radiation-induced clustered DNA lesions: Repair and mutagenesis. | Free Radic Biol Med | 2017 | https://conductscience.org/library/papers/27939934 | PubMed |
| 7 | 35850363 | Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma. | Int J Radiat Oncol Biol Phys | 2022 | https://conductscience.org/library/papers/35850363 | PubMed |
| 8 | 21617154 | Photodynamic therapy of cancer: an update. | CA Cancer J Clin | 2011 | https://conductscience.org/library/papers/21617154 | PubMed |
| 9 | 27877247 | Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy. | Theranostics | 2016 | https://conductscience.org/library/papers/27877247 | PubMed |
| 10 | 30156333 | Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization. | Adv Mater | 2019 | https://conductscience.org/library/papers/30156333 | PubMed |
| 11 | 40213580 | Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Efficacy in Pancreatic Cancer Models. | Small Sci | 2024 | https://conductscience.org/library/papers/40213580 | PubMed |
| 12 | 30523903 | The linear quadratic model: usage, interpretation and challenges. | Phys Med Biol | 2018 | https://conductscience.org/library/papers/30523903 | PubMed |
| 13 | 17877427 | Characterization of the theorectical radiation dose enhancement from nanoparticles. | Technol Cancer Res Treat | 2007 | https://conductscience.org/library/papers/17877427 | PubMed |
| 14 | 24569464 | Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24569464 | PubMed |
| 15 | 25746211 | Modelling energy deposition in nanoscintillators to predict the efficiency of the X-ray-induced photodynamic effect. | Nanoscale | 2015 | https://conductscience.org/library/papers/25746211 | PubMed |
| 16 | 32684987 | Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard? | Ther Adv Med Oncol | 2020 | https://conductscience.org/library/papers/32684987 | PubMed |
| 17 | 15509078 | The use of gold nanoparticles to enhance radiotherapy in mice. | Phys Med Biol | 2004 | https://conductscience.org/library/papers/15509078 | PubMed |
| 18 | 29413988 | LuAG:Pr3+-porphyrin based nanohybrid system for singlet oxygen production: Toward the next generation of PDTX drugs. | J Photochem Photobiol B | 2018 | https://conductscience.org/library/papers/29413988 | PubMed |
| 19 | 35020204 | Cancer statistics, 2022. | CA Cancer J Clin | 2022 | https://conductscience.org/library/papers/35020204 | PubMed |
| 20 | 35205732 | Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35205732 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42550387 | Landscape and evolutionary trends of nanotechnology in cancer radiosensitization. | Discov Nano | 2026 | https://conductscience.org/library/papers/42550387 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40959486
GET https://conductscience.org/api/papers/v1/40959486/references?page=2